Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis

Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis

Hepatitis B virus (HBV) infection is still one kind of the infectious diseases that seriously threaten human health. Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. HBV infection complicated with NAFLD is increasingly common. This review mainly de...

Full description

Bibliographic Details
Main Authors:	Lili Liu, Hong Li, Yang Zhang, Jing Zhang, Zhenhuan Cao
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Heliyon
Subjects:	Nonalcoholic fatty liver disease HBV infection Antiviral efficacy Liver fibrosis Hepatocellular carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023003201

Similar Items

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
by: Mohamed Salaheldin, et al.
Published: (2023-08-01)

Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis
by: Guizhi Zhang, et al.
Published: (2022-11-01)

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
by: Yuri Cho, et al.
Published: (2023-02-01)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
by: Tomomi Kogiso, et al.
Published: (2021-01-01)

The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease
by: A. S. Kuznetsova, et al.
Published: (2023-01-01)

Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis
by: He He, et al.
Published: (2023-09-01)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
by: Jung Hwan Yu, et al.
Published: (2023-02-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
by: Zihan Wei, et al.
Published: (2020-02-01)

Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
by: Reeju Amatya, et al.
Published: (2023-07-01)

Research progress of the impact of nonalcoholic fatty liver disease on chronic hepatitis B infection
by: BENEDICK Jun Er Chin, et al.
Published: (2023-12-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Chanbin Lee, et al.
Published: (2019-10-01)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
by: Margaret LP Teng, et al.
Published: (2023-04-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
by: Danny Orabi, et al.
Published: (2021-07-01)

Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
by: Ilias D. Vachliotis, et al.
Published: (2023-11-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Histone Demethylation Profiles in Nonalcoholic Fatty Liver Disease and Prognostic Values in Hepatocellular Carcinoma: A Bioinformatic Analysis
by: Yuanbin Liu, et al.
Published: (2023-04-01)

Nonalcoholic Fatty Liver Disease and the Kidney: A Review
by: Ilaria Umbro, et al.
Published: (2021-10-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Ferroptosis as an emerging therapeutic target in liver diseases
by: Yuzhen Lu, et al.
Published: (2023-05-01)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
by: Tamara Bassal, et al.
Published: (2022-11-01)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)

Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells
by: Liang'en Chen, et al.
Published: (2024-03-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Nonalcoholic fatty liver disease and outcomes in patients with acute coronary syndrome
by: El-Saied Shaheen
Published: (2018-01-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
by: Minah Kim, et al.
Published: (2021-05-01)

A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease
by: Ahmad Hassan Ali, et al.
Published: (2021-07-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)

Nonalcoholic Fatty Liver Disease and MicroRNAs: A Weighty Consideration
by: Sanjukta Mishra, et al.
Published: (2023-01-01)

Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)
by: Abeer Abdel-latif, et al.
Published: (2023-05-01)

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
by: Tatsuo Kanda, et al.
Published: (2020-09-01)

Association of Dietary Acid Load with Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in US Adults: Evidence from NHANES 1999–2018
by: Cheng J, et al.
Published: (2023-12-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies
by: Jin Chen, et al.
Published: (2022-01-01)

Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
by: Shang-Chin Huang, et al.
Published: (2022-11-01)